Msm-dtm

Msm-dtm has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 23, 2026: “A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration”.

Intervention

1 paper studies it2 findingsUpdated

  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals1

What did studies of Msm-dtm find?

2

Studies of Msm-dtm measured 2 outcomes; the most studied are tendon functional recovery (1 study) and pain (1).

Tendon functional recovery

upin animals1

1 study
  1. Msm-dtm improves tendon functional recovery.

    “In vivo, MSM-DTM improves collagen alignment, regulates macrophage polarization, alleviates pain, and enhances tendon functional recovery.”

    Animalsin vivo

    A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration

    Cell reports. Medicine

Pain

downin animals1

1 study
  1. Msm-dtm decreases pain.

    “In vivo, MSM-DTM improves collagen alignment, regulates macrophage polarization, alleviates pain, and enhances tendon functional recovery.”

    Animalsin vivo

    A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration

    Cell reports. Medicine

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months